XML 35 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations - Additional Information (Detail) (USD $)
12 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended
Dec. 27, 2010
Dec. 31, 2010
Senior Notes Due 2018
Oct. 22, 2010
Senior Notes Due 2018
Dec. 31, 2010
Cellu Tissue Holdings Inc
Dec. 31, 2010
Cellu Tissue Holdings Inc
Dec. 27, 2010
Cellu Tissue Holdings Inc
Dec. 27, 2010
Cellu Tissue Holdings Inc
Senior Notes Due 2018
Dec. 27, 2010
Cellu Tissue Holdings Inc
Credit Facility
Dec. 27, 2010
Cellu Tissue Holdings Inc
Industrial Bonds
Dec. 27, 2010
Cellu Tissue Holdings Inc
Common Stock Outstanding
Dec. 27, 2010
Cellu Tissue Holdings Inc
Stock Options And Restricted Stock Units
Business Acquisition [Line Items]                      
Business acquisition cash paid           $ 247,000,000       $ 242,200,000 $ 4,800,000
Business acquisition cash paid per share                     $ 12
Debt instrument, principal amount     375,000,000       375,000,000        
Debt instrument, interest rate     7.125%       7.125%        
Debt instrument, maturity date   Nov. 01, 2018         Nov. 01, 2018        
Goodwill 229,533,000         229,533,000          
Net sales       7,300,000              
Operating losses       (6,300,000)              
Pre-tax employee severance expenses       6,100,000              
Business acquisition costs recorded as selling, general and administrative expenses         20,400,000            
Debt retired and paid               32,500,000      
Business acquisition liabilities assumed $ 445,026,000               $ 15,600,000